RADT-25. EVALUATING LYMPHOCYTE COUNTS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION

BACKGROUND: Glioblastoma (GBM) patients are treated with chemotherapy, radiation therapy (RT) and often corticosteroids, which can all contribute to lymphopenia. We examined lymphopenia with respect to incidence, predictors, and association with progression-free survival (PFS) and overall survival (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Hammoudeh, Lubna, Lim-Fat, Mary Jane, Cagney, Daniel, Aizer, Ayal A, Tanguturi, Shyam, Arvold, Nils, Mcfaline-Figueroa, Jose, Chukwueke, Ugonma, Reardon, David, Lee, Eudocia, Nayak, Lakshmi, Rinne, Mikael, Ligon, Keith, Wen, Patrick, Alexander, Brian, Rahman, Rifaquat
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Clinical Radiotherapy
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651411/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.778
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares